Benefits of the Nephros Dual Stage Ultrafilter in Chronic Hemodialysis Patients: Evidence for Improved ESA Responsiveness

In conclusion, the use of the Nephros DSU to further reduce endotoxin exposure in chronic hemodialysis patients can result in improved erythropoiesis-stimulating agent (ESA) responsiveness and a lower ESA dose.Case Rep Nephrol Dial 2016;6:8-13
Source: Case Reports in Nephrology and Dialysis - Category: Urology & Nephrology Source Type: research